Pfizer, BioNTech Shares Tick Higher Following Study Results Out Of South Africa: Omicron Shows ‘Robust’ Escape to Vaccines But Protection Remains, Study Shows 40x Reduction In Neutralization Capacity Of Pfizer Vaccines vs Omicron